drugset / Trial / NCT01812330

Efficacy and Safety Study of Ticagrelor

NCT01812330

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the efficacy and safety of ticagrelor with clopidogrel

Timeline

Start
2013-01
Primary completion
2015-12
Completion
2016-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg
Subject Clopidogrel Small molecule 150 mg
Subject Ticagrelor Small molecule 90 mg Oral